(no title)
cliveowen | 11 years ago
http://www.economist.com/news/technology-quarterly/21615029-...
"One of these, Genia, is commercialising a process called nanopore sequencing that Dr Church first devised in 1988. Distinct polymer tags are attached to each of the four nucleotides poised to contribute to a single molecule of replicating DNA. As they react, the tags are released near a protein layer full of tiny holes called nanopores. Each tag blocks the flow of electrical ions across the layer in a different way. Because it relies on electronics rather than optics, nanopore sequencing promises faster, cheaper sequencing. Dr Church holds up a fingernail-sized chip containing 128,000 nanopores that he reckons will bring the cost of sequencing down to $100. In June, Genia was acquired by Roche, a Swiss pharmaceuticals giant."
No comments yet.